21st Jan 2009 07:00
Judges Capital plc
21 January 2009
Judges Capital plc
("Judges Capital" or the "Company")
Pre Close Trading Statement
The Directors of Judges Capital, the scientific instruments group, are pleased to announce a trading update in respect of the year ended 31 December 2008.
On 26 August 2008 the Company reported strong interim results for the six months ended 30 June 2008, while explaining that the first half performance should not be extrapolated in respect of the full-year.
On 17 November 2008, the Company announced that a reverse acquisition had been thwarted by the turbulence in financial markets and a £300,000 provision would be made to cover abortive costs. The Directors reported a satisfactory trading performance and expressed confidence in a good trading outcome for the year.
The Directors are pleased to report that the Group continued to operate strongly throughout the second half. Consequently, the Directors anticipate that the results for the year ended 31 December 2008 (excluding the provision for abortive costs) will be comfortably in excess of current market expectations. The Directors are also pleased to report that the Company entered the New Year with a record order book, substantially above the previous record figures at the onset of 2008. Such orders should, in the opinion of the Directors, secure a favourable performance during the early months of 2009 but the Directors are acutely aware of the risk that strong demand in our sector could be affected by the global economic downturn.
For further information please contact:
David Cicurel, CEO, Judges Capital: Tel: 01342 323 600
Pascal Keane, Shore Capital: Tel: 020 7408 4090
Melvyn Marckus, Cardew Group: Tel: 07775 896 491
Related Shares:
Judges Scientific